Ira Papel, MD
Facial Plastic Surgery · Baltimore, MDNPI 1700994548
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,100 of the $5,660 with a category attached, or 72.4%. 13 manufacturers reported payments, led by AbbVie at 45.7% of the total. Reporting peaked in 2021 at $1,959 and has fallen 63.5% since, to $714 in 2025.
Across 99 payments — averaging $57.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Galderma Laboratories, L.p.$639
- Stryker$232
- Baxter Healthcare$206
- Integra Lifesciences Corporation$199
- plus $744 from 7 others
Across 103 payments — averaging $7023.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$723K
What the payments were for
- Consulting fees$1,56028%
- Food & beverage$4,10072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $2,586 |
| Johnson & Johnson | 12 | $1,055 |
| Galderma Laboratories, L.p. | 27 | $639 |
| Stryker | 2 | $232 |
| Baxter Healthcare | 2 | $206 |
| Integra Lifesciences Corporation | 2 | $199 |
| Merz North America, Inc. | 4 | $180 |
| Revance Therapeutics, Inc. | 6 | $142 |
| Acclarent, Inc | 1 | $124 |
| Checkpoint Surgical, Inc | 1 | $99 |
| Lumenis, Inc | 1 | $94 |
| Alk-abello, Inc | 1 | $94 |
| Apyx Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$1,885
- TRUMATCH$657
- INTEGRA$509
- MATRIXMANDIBLE$407
- INTEGRA DERMAL REGENERATION TEMPLATE$170
- PRIMATRIX$170
- XPRESS LOPROFILE$140
- TruDi$124
- TISSEEL$121
- MATRIXMIDFACE$120
- CEMENTRALIZER$105
How this compares
Too few facial plastic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 24 | $220 |
| Cefadroxil | 24 | $123 |
| Oxycodone Hcl | 20 | $57 |
| Ondansetron OdtOndansetron | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Baltimore
- Randolph CaponeBaltimore$44K
- Theda KontisBaltimore$16K
- Brandon WachalAnnapolis$4K
- Lee KleimanSeverna Park$4K
- Henry SandelAnnapolis$2K
- Jennifer PorterBethesda$2K
- Jigar SitaparaColumbia$1K
- Thong leEllicott City$539
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.